EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ebola vaccine trial aims to shield frontline workers in congo
⭐️ VACCINE ⭐️ CompletedThis study tests a two-dose Ebola vaccine regimen in healthcare workers in the Democratic Republic of the Congo, who are at high risk during outbreaks. Participants receive an initial shot of Ad26.ZEBOV followed by a booster of MVA-BN-Filo 56 days later. Some will also get an add…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE2 • Sponsor: Universiteit Antwerpen • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
Hope in a pill? ebola drug favipiravir tested in guinea
Disease control CompletedThis completed Phase 2 trial tested the antiviral drug favipiravir in 126 people with Ebola in Guinea. The goal was to see if it could reduce deaths. Participants received high doses of the drug by mouth for up to 10 days. The study aimed to find a practical treatment for Ebola, …
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Ebola survivors under the microscope: what happens after recovery?
Knowledge-focused CompletedThis completed study in the Democratic Republic of the Congo followed 787 people who survived Ebola and their close contacts. Researchers tracked their health over time, looking for lingering virus, immune responses, and other infections. The goal was to better understand the lon…
Matched conditions: EBOLA VIRUS DISEASE
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC